Biomarker analysis and updated results from the Phase III PROpel trial of abiraterone (abi) and olaparib (ola) vs abi and placebo (pbo) as first-line (1L) therapy for patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
dc.contributor.author | Saad, F. | |
dc.contributor.author | Armstrong, A. J. | |
dc.contributor.author | Thiery-Vuillemin, A. | |
dc.contributor.author | Oya, M. | |
dc.contributor.author | Shore, N. D. | |
dc.contributor.author | Procopio, G. | |
dc.contributor.author | Arslan, C. | |
dc.contributor.author | Mehra, N. | |
dc.contributor.author | Parnis, F. | |
dc.contributor.author | Brown, E. | |
dc.contributor.author | Schlurmann, F. C. | |
dc.contributor.author | Joung, J. Y. | |
dc.contributor.author | Sugimoto, M. | |
dc.contributor.author | Sartor, O. | |
dc.contributor.author | Liu, Y. Z. | |
dc.contributor.author | Poehlein, C. H. | |
dc.contributor.author | Desai, C. | |
dc.contributor.author | Del Rosario, P. M. D. | |
dc.contributor.author | Clarke, Noel W | |
dc.date.accessioned | 2023-01-24T10:32:25Z | |
dc.date.available | 2023-01-24T10:32:25Z | |
dc.date.issued | 2022 | en |
dc.identifier.citation | Saad F, Armstrong AJ, Thiery-Vuillemin A, Oya M, Shore ND, Procopio G, et al. Biomarker analysis and updated results from the Phase III PROpel trial of abiraterone (abi) and olaparib (ola) vs abi and placebo (pbo) as first-line (1L) therapy for patients (pts) with metastatic castration-resistant prostate cancer (mCRPC). Annals of Oncology. 2022 Sep;33(7):S1160-S. PubMed PMID: WOS:000866211601614. | en |
dc.identifier.doi | 10.1016/annonc/annonc1070 | en |
dc.identifier.uri | http://hdl.handle.net/10541/625972 | |
dc.language.iso | en | en |
dc.relation.url | https://dx.doi.org/10.1016/annonc/annonc1070 | en |
dc.title | Biomarker analysis and updated results from the Phase III PROpel trial of abiraterone (abi) and olaparib (ola) vs abi and placebo (pbo) as first-line (1L) therapy for patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) | en |
dc.type | Meetings and Proceedings | en |
dc.contributor.department | Department Of Urology, Centre Hospitalier de l’Université de Montréal/CRCHUM, Université de Montreal, H2X 3J4 | en |
dc.identifier.journal | Annals of Oncology | en |
dc.description.note | en] |